肉毒毒素注射治疗逆行性环咽肌功能障碍:一项前瞻性队列研究
这项前瞻性队列研究比较手术室(80U)与诊室(30U)肉毒毒素注射治疗逆行性环咽肌功能障碍的效果与副作用。108例完成治疗前问卷,53例完成3周随访,36例完成3个月问卷。两组症状评分在3周和3个月均显著降低且组间无差异,但手术室组注射后吞咽困难(EAT-10)评分显著高于诊室组,焦虑评分两组均显著下降。
要点
- 手术室与诊室肉毒毒素注射治疗逆行性环咽肌功能障碍同样有效。
- 手术室注射后吞咽困难较诊室注射更重,可能与所用肉毒毒素剂量较高有关。
- 治疗后一般焦虑水平下降。
核心结论
- 手术室与诊室注射肉毒毒素治疗逆行性环咽肌功能障碍同样有效。
- 手术室注射后吞咽困难更严重,可能与所用肉毒毒素剂量较高有关。
- 一般焦虑水平随治疗下降。
研究设计与样本
- 前瞻性队列研究,纳入18岁以上、具有无法嗳气、腹部、胸部或颈部咕噜声、腹胀及排气过多并诊断为逆行性环咽肌功能障碍的患者。
- 注射由资深作者在手术室(80U)或诊室(30U)施行。
- 108例(55男/53女)完成治疗前问卷,53例(手术室31例 vs 诊室22例)完成3周随访,36例(手术室22例 vs 诊室14例)完成3个月问卷。
- 采用线性混合模型分析肉毒毒素注射对逆行性环咽肌功能障碍症状、EAT-10及GAD-7的影响。
主要发现
- 两组治疗后平均逆行性环咽肌功能障碍评分在3周和3个月均显著降低(p < 0.0001)。
- 诊室与手术室注射之间无差异(p = 0.4924)。
- 两组GAD-7评分在第3周(p = 0.0018)和第3个月(p = 0.0012)均显著降低。
- 注射后EAT-10评分手术室组显著高于诊室组(p = 0.0379)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Retrograde Cricopharyngeal Dysfunction (RCPD) is treated by botulinum toxin (BTX) injection into the cricopharyngeus. This prospective study compares the effectiveness and side effects of operating room (OR) and in-office (IO) injections. METHODS: Patients over 18 years of age with inability to burp, abdominal, thoracic, or cervical gurgling sounds, bloating, and excessive flatulence were diagnosed with RCPD and included in the study. Injections were performed in the OR (80U) or IO (30U) by the senior author. An RCPD questionnaire quantifying major and minor symptoms on a Likert scale, Eating Assessment Tool-10 (EAT-10), and Generalized Anxiety Score-7 (GAD-7), were completed preinjection; at 1, 2, and 3 weeks; and 3 months postoperatively. Linear mixed models were used to analyze effects of BTX injection on RCPD symptoms, the EAT-10, and the GAD-7. RESULTS: 108 (55 M/53F) patients completed the pretreatment survey, 53 (31 OR vs. 22 IO) completed the 3-week follow-up, and 36 (22 OR vs. 14 IO) completed the 3-month questionnaire. Average posttreatment RCPD scores were significantly lower in both groups at 3 weeks and 3 months (p < 0.0001), There was no difference between IO or OR (p = 0.4924). GAD-7 scores were significantly lower in both groups at week 3 (p = 0.0018) and month 3 (p = 0.0012). Postinjection EAT-10 scores were significantly higher in OR compared with IO (p = 0.0379). CONCLUSION: OR and IO injections are equally effective in the treatment of RCPD. Postinjection dysphagia is more severe after the OR injections which may be related to higher doses of BTX used. General anxiety levels decrease with treatment. LEVEL OF EVIDENCE: 2 Laryngoscope, 134:4614-4619, 2024.
引用
- Doruk C, Kennedy EL, Tipton C, et al. Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction: A Prospective Cohort Study. Laryngoscope. 2024. PMID: 38895836. doi:10.1002/lary.31591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。